Oorsprong van het eerstegraads netwerk van Unni Hjelmaas
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.
16
| Extinct | Pharmaceuticals: Other | 16 |
| Public Company | Pharmaceuticals: Major | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Unni Hjelmaas via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SOLON EIENDOM ASA | Real Estate Development | Founder Director/Board Member Chief Executive Officer Founder Comptroller/Controller/Auditor Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Basel | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Director/Board Member Undergraduate Degree | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Doctorate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer General Counsel | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Comptroller/Controller/Auditor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Copenhagen Business School | College/University | Masters Business Admin Graduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree | |
| BI Norwegian Business School | College/University | Graduate Degree Graduate Degree | |
Central New Jersey Council Boy Scouts of America
 Central New Jersey Council Boy Scouts of America Miscellaneous Commercial ServicesCommercial Services Central New Jersey Council Boy Scouts of America provides programs, events and opportunities of a lifetime that serve to shape the lives of young men and women in Central and Northern New Jersey. The company was founded in 1995 and is headquartered in Monmouth Junction, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| PTC Corp. | Director/Board Member | ||
The Arthritis Foundation
 The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Arthritis Foundation provides funds research, advocacy and support services for various kinds of arthritis and related diseases. It offers programs and services including aquatic programs, information about treatment breakthroughs, exercise tips for people with the disease and pain management information. Arthritis Foundation is located in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Semorex, Inc. | Director/Board Member | ||
| International Castlemans Disease Organization | Director/Board Member | ||
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImmuneRegen BioSciences, Inc.
 ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneRegen BioSciences, Inc. researches and develops immunomodulation to improve pulmonary function and stimulating the human immune system. The company is headquartered in Scottsdale, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Doctorate Degree | |
| Brown University | College/University | Graduate Degree | |
| University of California, Davis | College/University | Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Mali Health Organizing Project | Director/Board Member | ||
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Celgene Global Health | Chief Executive Officer | ||
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
| METASTAT, INC. | Electrical Products | Chairman | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Aventis, Inc. | Corporate Officer/Principal | ||
| IR BIOSCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 35 |
| Noorwegen | 4 |
| Zwitserland | 4 |
| Verenigd Koninkrijk | 4 |
| Denemarken | 4 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 193 |
| Chairman | 61 |
| Corporate Officer/Principal | 58 |
| Independent Dir/Board Member | 45 |
| Chief Executive Officer | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Franz Humer | 45 |
| Jerome Zeldis | 38 |
| Benedicte Fossum | 27 |
| Phyllis Whiteley | 26 |
| David Solomon | 22 |
| Clive Meanwell | 21 |
| Domenico Scala | 20 |
| Stephen Hill | 18 |
| Kirsten Drejer | 18 |
| Helene Jebsen Anker | 15 |
| Barbara Ruskin | 12 |
| Eduard Enrico Holdener | 11 |
| Thomas Hofstaetter | 10 |
| Rolf Hänggi | 8 |
- Beurs
- Insiders
- Unni Hjelmaas
- Bedrijfsconnecties
